T CELL AND B CELL RECEPTOR SEQUENCING REVEALS ANTI-CANCER IMMUNE RESPONSE ASSOCIATED WITH IMMUNE-RELATED ADVERSE EVENTS IN ADVANCED RENAL CELL CARCINOMA PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS

被引：0
|
作者：
Kato, Taigo
Kiyotani, Kazuma
Ishizuya, Yu
Yamamoto, Yoshiyuki
Hatano, Koji
Kawashima, Atsunari
Nonomura, Norio
机构：
来源：
JOURNAL OF UROLOGY | 2023年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP04-14
引用
收藏
页码：E38 / E39
页数：2
相关论文
共 50 条
  • [1] Immune-Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors
    Martini, Dylan J.
    Goyal, Subir
    Liu, Yuan
    Evans, Sean T.
    Olsen, T. Anders
    Case, Katherine
    Magod, Benjamin L.
    Brown, Jacqueline T.
    Yantorni, Lauren
    Russler, Greta Anne
    Caulfield, Sarah
    Goldman, Jamie M.
    Nazha, Bassel
    Harris, Wayne B.
    Kissick, Haydn T.
    Master, Viraj A.
    Kucuk, Omer
    Carthon, Bradley C.
    Bilen, Mehmet Asim
    ONCOLOGIST, 2021, 26 (10): : E1742 - E1750
  • [2] Management of Immune-Related Adverse Events from Immune-Checkpoint Inhibitors in Advanced or Metastatic Renal Cell Carcinoma
    Leucht, Katharina
    Ali, Nalyan
    Foller, Susan
    Grimm, Marc-Oliver
    CANCERS, 2022, 14 (18)
  • [3] Immune-Related Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitors
    Sandigursky, Sabina
    Mor, Adam
    CURRENT RHEUMATOLOGY REPORTS, 2018, 20 (10)
  • [4] Immune-Related Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitors
    Sabina Sandigursky
    Adam Mor
    Current Rheumatology Reports, 2018, 20
  • [5] Risk Factors of Immune Related Adverse Events in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors
    Chehade, Razane El Hajj
    Semaan, Karl
    Saliby, Renee Maria
    Saad, Eddy
    Nawfal, Rashad
    Machaalani, Marc
    Eid, Marc
    Yekeduz, Emre
    Steiner, Clara
    Sun, Maxine
    Kaymakcalan, Marina
    Choueiri, Toni K.
    ONCOLOGIST, 2024, 29
  • [6] Immune-related adverse events associated with immune checkpoint inhibitors in patients with cancer
    Samanci, Nilay Sengul
    Cikman, Duygu Ilke
    Oruc, Kerem
    Bedir, Sahin
    Celik, Emir
    Degerli, Ezgi
    Derin, Sumeyra
    Demirelli, Fuat Hulusi
    Ozguroglu, Mustafa
    TUMORI JOURNAL, 2021, 107 (04): : 304 - 310
  • [7] Single-cell RNA sequencing reveals distinct T cell populations in immune-related adverse events of checkpoint inhibitors
    Bukhari, Shoiab
    Henick, Brian S.
    Winchester, Robert J.
    Lerrer, Shalom
    Adam, Kieran
    Gartshteyn, Yevgeniya
    Maniar, Rohan
    Lin, Ziyan
    Khodadadi-Jamayran, Alireza
    Tsirigos, Aristotelis
    Salvatore, Mary M.
    Lagos, Galina G.
    Reiner, Steven L.
    Dallos, Matthew C.
    Mathew, Matthen
    Rizvi, NaiyerA.
    Mor, Adam
    CELL REPORTS MEDICINE, 2023, 4 (01)
  • [8] Biomarkers for immune-related adverse events in cancer patients treated with immune checkpoint inhibitors
    Liang, Yao
    Maeda, Osamu
    Ando, Yuichi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, : 365 - 375
  • [9] Immune-related adverse events in cancer patients being treated with immune checkpoint inhibitors
    Byrne, Margaret M.
    Lucas, Mathew
    Pai, Lori
    Breeze, Janis
    Parsons, Susan K.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 107 (06) : 650 - 657
  • [10] Immune Checkpoint Inhibitors and Immune-Related Adverse Renal Events
    Herrmann, Sandra M.
    Perazella, Mark A.
    KIDNEY INTERNATIONAL REPORTS, 2020, 5 (08): : 1139 - 1148
12345